F. Gonzalez et al., HYPOPHOSPHATEMIC OSTEOMALACIA IN A RENAL- ALLOGRAFT RECIPIENT - A CAUSE OF SEVERE OSTEOPOROSIS, Revista Medica de Chile, 123(1), 1995, pp. 85-89
Renal osteodystrophy improves after renal transplantation but, after t
he procedure, other forms of bone disease emerge. We report a male pat
ient that received a renal allograft four years before, who consulted
for low back pain secondary to multiple verebral compression fractures
. The patient had good renal funtion, a parathormone independent hyper
phosphaturia, normal 25-OH cholecalciferol, increased urinary hydroxyp
roline, decreased osteocalcin, reduced bone density and a bone biopsy
revealing osteomalacia. The diagnosis of hypophosphemic osteomalacia w
as reached and treatment with phosphates and ergocalciferol was starte
d but, despite this, the patient suffered a new fracture two years lat
er. Two mechanisms can produce hypophosphatemia after a renal transpla
ntation: a parathormone excess due to the preview renal failure, that
disappears during the first year after the transplantation or a derang
ement in renal phosphate transport that can be due to a generalized pr
oximal tubule solute transport derangement (Fanconi syndrome), paratho
rmone hypersensitivity or to an ''idiopathic'' hyperphosphaturia. Desp
ite a good treatment, bone mass is not recovered and there is a high f
racture risk. Mineral metobolism must be closely monitored after a ren
al allograft and its alterations must be quickly treated.